CABR Stock Analysis: Buy, Sell, or Hold?
$1.34
-0.28 (-17.08%)
▼
5d:
-16.04%
30d:
+1.14%
90d:
+42.87%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 11, 2026
1d
Get Alerted When CABR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CABR is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CABR is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CABR is currently trading at $1.33, which is considered slightly low relative to its 30-day fair value range of $1.32 to $1.53.
Technical Outlook: Technically, CABR is in a strong uptrend. Immediate support is located at $1.28, while resistance sits at $1.84. Short-term momentum is weak, with the stock down 17.1% recently.
Market Sentiment: CABR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CABR is in a strong uptrend. Immediate support is located at $1.28, while resistance sits at $1.84. Short-term momentum is weak, with the stock down 17.1% recently.
Market Sentiment: CABR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.32 -
$1.53
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-17.1%)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.32 -
$1.53
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.84
Current Trend
Strong Uptrend
Technical data as of
Aug 7, 2026
Fundamental Context
Revenue Growth (YoY)
-9.7%
Share & Embed Analysis
Last updated: August 09, 2026 12:17 AM ET
Data refreshes hourly during market hours. Next update: 1:17 AM
Data refreshes hourly during market hours. Next update: 1:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 59 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 47 HOLD |